In last decades, biologic therapies have been approved for severe allergic and/or eosinophilic asthma. Limited studies have investigated the effect of biologics on (acute) cardiovascular events, which ...

Scientists believe the breakthrough could lead to new protection for millions of people living with food allergies. The post Asthma drug could potentially prevent deadly food allergies: study appeared ...

Potentially deadly food allergies could be prevented by an asthma drug, according to new research. Zileuton worked "shockingly well" in blocking allergic reactions to food in mice, say scientists.

By using to block the pathway involving this gene, the team at Northwestern University in Illinois nearly eliminated allergic responses in mice that were previously highly susceptible to food-induced ...

Uncover the recent breakthroughs in asthma-targeted therapy.

Apogee Therapeutics, Inc. had promising results from its APG808 Phase 1b study show potential for every 2-month asthma treatment. Click for my APGE stock update.

About APG808 APG808 is a novel, subcutaneous extended half-life monoclonal targeting IL-4Rα, a target with clinical validation across eight Type 2 allergic diseases, for the potential treatment of ...

Asthma causes difficulty breathing, wheezing, and shortness of breath.

Roughly 860,000 Illinois residents have asthma. Most of them can manage their condition without medication, or with simple inhalers. But for the most severe cases, patients often need specialized ...

Asthma patients in Illinois need continued coverage for infusion center treatments Blue Cross Blue Shield shouldn’t expect serious asthma patients in Illinois to begin to administer their own ...